$500+ Million Worldwide Tumor Ablation Therapy Devices Industry to 2031 - Increasing Prevalence of Cancer is a Key Driving Factor - ResearchAndMarkets.com

2022-11-23

DUBLIN--(BUSINESS WIRE)--The "Tumor Ablation Therapy Devices Global Market Report 2022" report has been added to ResearchAndMarkets.com's offering.

'Tumor Ablation Therapy Devices Global Market Report 2022'

This report provides strategists, marketers and senior management with the critical information they need to assess the global tumor ablation therapy devices market.

The global tumor ablation therapy devices market is expected to grow from $0.49 billion in 2021 to $0.56 billion in 2022 at a compound annual growth rate (CAGR) of 14.1%. The market is expected to grow to $0.97 billion in 2026 at a compound annual growth rate (CAGR) of 15%.

Companies Mentioned

Galil Medical inc.

Misonix inc.

HealthTronics

Angiodynamics

Boston Scientific Corporation

Medtronic Plc.

EDAP TMS S.A.

Neuwave Medical inc.

BVM Medical Limited

Erbe Elektromedizin GmbH

BTG International ltd.

AtriCure, Inc.

Theraclion

INTIO Inc.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies

Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates

Create regional and country strategies on the basis of local data and analysis

Identify growth segments for investment

Outperform competitors using forecast data and the drivers and trends shaping the market

Understand customers based on the latest market research findings

Benchmark performance against key competitors

Utilize the relationships between key data sets for superior strategizing

Suitable for supporting your internal and external presentations with reliable high quality data and analysis

The tumor ablation therapy devices market consists of sales of tumor ablation devices and related services that are used in hospitals and oncology clinics. Tumor ablation is the technique used to extract the tumors using a needle, to insert them in the tumor organ using imaging techniques.

The main technologies in the tumor ablation therapy devices are radiofrequency ablation, microwave ablation, cryoablation, irreversible electroporation ablation, and others. Irreversible electroporation (IRE) in tumor ablation therapy is a new tissue ablation method in which micro to millisecond electrical pulses are supplied to undesirable tissue to produce cell necrosis by irreversible cell membrane permeabilization. The treatments included are surgical, laparoscopic, and percutaneous that are used in various applications such as kidney cancer, liver cancer, breast cancer, lung cancer, prostate cancer, and others. The various end-users of tumor ablation therapy devices are hospitals, oncology clinics, and others.

North America was the largest region in the tumor ablation therapy devices market in 2021. Asia Pacific was the second largest region in the tumor ablation therapy devices market. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The increasing prevalence of cancer is a key factor driving the growth of the tumor ablation therapy devices market. Cancer is considered to be the second major cause of death, with around 1 in 6 deaths due to cancer worldwide. Tumor ablation is a minimally invasive procedure widely used in the treatment of lung, liver, kidney, and bone tumors.

Product recalls of tumor ablation devices due to technical issues are expected to hinder the growth of the tumor ablation therapy devices market. The companies are retrieving their products from the market due to safety concerns.

For instance, Covidien Emprint Long Percutaneous Antenna with Thermosphere Technology, a tumor ablation device from Medtronic had recalled its devices due to the disengagement of ceramic trocar tip of the Emprint ablation from the needle shaft post-ablation. Similarly, in June 2018, Accurian RF Ablation by Medtronic Sofamor Danek USA Inc was recalled due to the difficulty in insertion. The product recalls caused a financial burden on the companies hindering the tumor ablation therapy devices market.

Major companies operating in the tumor ablation therapy devices are focusing on technology advancements for shorter procedures, increased safety, lower exposure to radiation, faster learning curves, and improved outcomes J&J medicals have released a microwave ablation system called NEUWAVE, which is the first minimally invasive device to put electrodes into cancer cells and thereby increase the temperature around them for burning the cancer cells.

The countries covered in the tumor ablation therapy devices market are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, and USA.

For more information about this report visit https://www.researchandmarkets.com/r/xgg89p